tiprankstipranks
Logicbio Therapeutics Inc (LOGC)
NASDAQ:LOGC

Logicbio Therapeutics (LOGC) Income Statement

0 Followers

Logicbio Therapeutics Income Statement

Last quarter (Q ), Logicbio Therapeutics's total revenue was $3.20M, an increase of 298.88% from the same quarter last year. In Q, Logicbio Therapeutics's net income was $-5.04M. See Logicbio Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Dec 21Dec 20Dec 19Dec 18Dec 17
Total Revenue
$ 10.16M$ 5.41M$ 3.45M$ 0.00$ 0.00$ 0.00
Cost of Revenue
------
Gross Profit
------
Operating Expense
$ 40.25M$ 44.40M$ 34.97M$ 41.04M$ 17.94M$ 5.85M
Operating Income
$ -30.09M$ -38.98M$ -31.51M$ -41.04M$ -17.94M$ -5.85M
Net Non Operating Interest Income Expense
$ -875.00K$ -1.05M$ -917.00K$ 954.00K$ 567.00K$ 54.00K
Other Income Expense
$ -18.00K$ -18.00K$ -5.00K$ -19.00K$ -159.00K$ 67.00K
Pretax Income
$ -30.98M$ -40.06M$ -32.43M$ -40.11M$ -17.54M$ -5.73M
Tax Provision
$ -28.00K$ -28.00K$ 188.00K$ 22.00K$ 86.00K$ 62.00K
Earnings From Equity Interest Net Of Tax
------
Net Income Common Stockholders
$ -30.95M$ -40.03M$ -32.62M$ -40.13M$ -17.62M$ -7.74M
Basic EPS
$ -0.94$ -1.24$ -1.29$ -1.78$ -3.04$ -0.57
Diluted EPS
$ -0.94$ -1.24$ -1.29$ -1.78$ -3.04$ -0.57
Basic Average Shares
$ 131.32M$ 32.38M$ 25.36M$ 22.60M$ 5.80M$ 13.67M
Diluted Average Shares
$ 131.32M$ 32.38M$ 25.36M$ 22.60M$ 5.80M$ 13.67M
Dividend Per Share
------
Total Operating Income As Reported
------
Reported Normalized Basic E P S
------
Reported Normalized Diluted E P S
------
Rent Expense Supplemental
------
Total Expenses
$ 40.25M$ 44.40M$ 34.97M$ 41.04M$ 17.94M$ 5.85M
Net Income From Continuing And Discontinued Operation
$ -30.95M$ -40.03M$ -32.62M$ -40.13M$ -17.62M$ -5.79M
Normalized Income
$ -30.95M$ -40.03M$ -32.62M$ -40.13M$ -17.62M$ -5.79M
Interest Expense
$ 931.00K$ 1.07M$ 1.10M$ 546.00K$ 2.00K-
EBIT
$ -30.05M$ -38.99M$ -31.34M$ -39.56M$ -17.53M$ -5.85M
EBITDA
$ -29.37M$ -38.36M$ -30.86M$ -39.27M$ -17.44M$ -5.81M
Currency in USD

Logicbio Therapeutics Earnings and Revenue History

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis